Our Philadelphia Essure Birth Control Lawyers are evaluating cases involving women who sustained fatal or non-fatal injuries from the permanent birth control device, Essure. Conceptus, Inc., a company owned by Bayer, developed the Essure device as an alternative to other permanent birth control (sterilization) methods that require surgery.
The Essure birth control device is a pair of metal coils that a physician inserts in a woman’s fallopian tubes. (The doctor inserts one coil into each tube through the woman’s vagina and cervix.) Essure birth control works by causing scar tissue to form around the coils. The scar tissue provides a barrier between sperm and eggs released from the ovaries, preventing a woman in whom the device has been inserted from becoming pregnant.
Serious Injuries Linked to Essure Birth Control
Thousands of women have lodged complaints with the U.S. Food and Drug Administration (FDA) regarding complications and injuries from Essure birth control. The metal coils that comprise the Essure birth control device can break apart and travel to other parts of a woman’s body. The migrating pieces of metal can pierce (puncture) or tear a woman’s:
- fallopian tubes
The FDA granted pre-market approval for Essure in 2002. Bayer did not include a warning regarding the risks of Essure device migration until 2013. In 2016, the FDA required the addition of a black box warning regarding the life-threatening dangers of the Essure birth control device.
Women injured by breakage and migration of Essure often suffer additional complications from surgery that was required:
- to repair internal injuries caused by Essure, and
- to remove dangerous pieces of broken Essure devices to prevent further damage
Some women have required a hysterectomy due to injuries caused by Essure.
Essure Birth Control Lawsuits
Essure injury lawsuits filed by Philadelphia Essure Birth Control Lawyers allege that Bayer:
- designed and manufactured a defective medical device
- knew of the dangerous complications and side effects associated with the Essure birth control device
- failed to adequately warn physicians and consumers of the risks
- failed to provide evidence of known risks of Essure to the FDA for purposes of obtaining pre-market approval of Essure